KR100859986B1 - Fomitopsis pinicola Extract Having Diabetes Complication Preventive Effect and The Use Thereof - Google Patents

Fomitopsis pinicola Extract Having Diabetes Complication Preventive Effect and The Use Thereof Download PDF

Info

Publication number
KR100859986B1
KR100859986B1 KR1020070026809A KR20070026809A KR100859986B1 KR 100859986 B1 KR100859986 B1 KR 100859986B1 KR 1020070026809 A KR1020070026809 A KR 1020070026809A KR 20070026809 A KR20070026809 A KR 20070026809A KR 100859986 B1 KR100859986 B1 KR 100859986B1
Authority
KR
South Korea
Prior art keywords
extract
pine
delete delete
butterfly
glucose
Prior art date
Application number
KR1020070026809A
Other languages
Korean (ko)
Other versions
KR20070073656A (en
Inventor
오승희
김순동
이상일
이현구
Original Assignee
유진바이오팜영농조합법인
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유진바이오팜영농조합법인 filed Critical 유진바이오팜영농조합법인
Priority to KR1020070026809A priority Critical patent/KR100859986B1/en
Publication of KR20070073656A publication Critical patent/KR20070073656A/en
Application granted granted Critical
Publication of KR100859986B1 publication Critical patent/KR100859986B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/15Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 소나무잔나비버섯 추출물 및 그 용도에 관한 것이다. 본 발명의 소나무잔나비버섯 자실체 추출물 및 배양균사체 추출물은 수정체 및 신장의 알도스환원효소(aldose reductase)의 활성을 억제하고, 중성지질, 총 콜레스테롤 및 LDL 콜레스테롤의 농도를 감소시키므로, 백내장 또는 신장병 등의 당뇨합병증과 같은 알도스환원효소의 활성증가에 기인하는 질환의 치료 또는 예방효과를 나타내는 기능성 식품의 개발에 널리 활용될 수 있을 것이다. The present invention relates to pine needles mushroom extract and its use. Pine needles fruiting body extract and culture mycelia extract of the present invention inhibits the activity of aldose reductase of the lens and kidney, and reduces the concentration of neutral lipids, total cholesterol and LDL cholesterol, such as cataracts or kidney disease The present invention may be widely used for the development of functional foods that exhibit a therapeutic or prophylactic effect of diseases caused by increased activity of aldose reductase, such as diabetic complications.

소나무잔나비버섯, 당뇨합병증, 알도스환원효소, β-1,3-글루카노-β-1,6-헤테로갈락토만난-단백질복합체 Pineapple Butterfly, Diabetic Complications, Aldose Reductase, β-1,3-Glucano-β-1,6-heterogalactomannan-protein Complex

Description

당뇨합병증 예방효과를 나타내는 소나무잔나비버섯 추출물 및 그 용도{Fomitopsis pinicola Extract Having Diabetes Complication Preventive Effect and The Use Thereof}Fomitopsis pinicola extract having diabetes complication preventive effect and the use thereof}

도 1은 당뇨 및 당뇨합병증의 발생 기작에 대한 도표이다. 폴리올 경로 내의 알도스환원효소가 포도당을 솔비톨로 대사하는데 관여하며, 전기 알도스환원효소의 활성을 억제함으로써 당뇨합병증으로의 진행이 차단된다.1 is a chart of the mechanism of development of diabetes mellitus and diabetic complications. The aldose reductase in the polyol pathway is involved in metabolizing glucose into sorbitol and inhibits the activity of the former aldose reductase to block progression to diabetic complications.

도 2는 시험관 내에서 소나무잔나비버섯 자실체 열수추출물 첨가에 의한 흰쥐 수정체의 알도스환원효소의 활성변동 효과를 나타낸 그래프이다. Figure 2 is a graph showing the effect of aldose reductase activity of the rat lens by the addition of pine needles fruiting body hot water extract in vitro.

도 3은 흰쥐 수정체 알도스환원효소의 동력학에 미치는 소나무잔나비버섯 자실체 열수추출물의 영향을 나타낸 그래프이다. Figure 3 is a graph showing the effect of pine needles mushroom fruiting hot water extract on the kinetics of the lens aldose reduction enzyme in rats.

본 발명은 소나무잔나비버섯 추출물 및 그 용도에 관한 것이다. 좀 더 구체 적으로, 본 발명은 백내장, 신장병 등의 당뇨합병증과 같은 알도스환원효소의 활성증가에 기인하는 질병의 예방효과를 나타내는 소나무잔나비버섯 자실체 추출물 및 배양균사체 추출물에 관한 것이다. The present invention relates to pine needles mushroom extract and its use. More specifically, the present invention relates to pine needles and fruit mycelia extracts exhibiting the preventive effect of diseases caused by increased activity of aldose reductase, such as diabetic complications such as cataracts, kidney disease.

식습관이 서구화됨에 따라 비만과 고지혈증 및 당뇨와 같은 생활습관병의 발생율이 현저히 증가하고 있어 심각한 사회문제가 되고 있다. 특히, 한국인의 당뇨병 발생율은 최근 10년 사이에 급증하여 한국인의 사망요인 중 4위에 이르고 있는 실정이다(참고: 사망원인 통계에 관한 연간 보고서 1999, 2002). As the eating habits are westernized, the incidence of lifestyle diseases such as obesity, hyperlipidemia, and diabetes is increasing, which is a serious social problem. In particular, the incidence of diabetes among Koreans has risen sharply in recent decades, making it the fourth largest cause of death among Koreans (see Annual Report on Cause of Death Statistics, 1999, 2002).

당뇨병은 인슐린 의존성인 제 1형 당뇨와 인슐린 비의존성인 제 2형 당뇨로 분류되는데, 당뇨병의 약 90 내지 95% 정도가 제 2형 당뇨로 알려져 있다. 호르몬 불균형에 의해 당뇨병이 발생하면 탄수화물을 비롯한 3대 영양소의 대사가 비정상적으로 진행되어 고혈당과 더불어 혈중의 중성지방과 총 콜레스테롤 및 LDL 콜레스테롤의 농도가 증가하고 HDL 콜레스테롤의 함량은 감소하는 등 지질대사에 심각한 변화가 초래되어 동맥경화증이 유발되고 이로 인하여 심순환계 질환과 더불어 신경장애 및 신장 손상 등을 비롯한 합병증이 야기되어 사망에 이르는 것으로 알려지고 있다. Diabetes is classified into insulin-dependent type 1 diabetes and insulin-independent type 2 diabetes. About 90 to 95% of diabetes is known as type 2 diabetes. When diabetes develops due to hormonal imbalance, metabolism of the three major nutrients including carbohydrates is abnormally progressed, resulting in high blood sugar, increased levels of triglycerides, total cholesterol and LDL cholesterol in the blood, and decreased content of HDL cholesterol. It is known that severe changes cause atherosclerosis, which causes cardiovascular disease, complications including neurological disorders and kidney damage, leading to death.

한편, 당뇨병이 발생하여 고혈당이 지속되면 정상적인 당질대사과정인 혐기적 해당과정에 관여하는 헥소키나아제가 포화됨으로서 과잉의 포도당이 당질대사의 부 대사과정인 폴리올 경로(polyol pathway)의 알도스환원효소(aldose reductase)에 의해 솔비톨로 대사되고 다시 솔비톨 탈수소효소에 의해 과당으로 대사된다. 이 때, 생성된 솔비톨은 세포막 투과도가 낮아 삼투압 스트레스를 야기시켜 조직세포의 손상을 초래하게 되며 또한, 과잉의 포도당이나 과잉으로 생성된 과당은 단백질과 결합하여 최종당화산물(AGEs)를 생성함으로서 조직의 손상을 야기시키거나 활성산소종(ROS)을 생성함으로서 조직의 손상을 야기시켜 당뇨합병증을 유발시키는 것으로 알려져 있다. On the other hand, when diabetes occurs and hyperglycemia persists, hexokinase that is involved in anaerobic glycolysis, a normal carbohydrate metabolism, is saturated, so that excess glucose is an aldose reductase enzyme of the polyol pathway, a metabolic process of glucose metabolism. It is metabolized to sorbitol by aldose reductase and to fructose by sorbitol dehydrogenase. At this time, the sorbitol produced has a low cell membrane permeability, causing osmotic stress, which causes tissue cell damage. In addition, excess glucose or excess fructose is combined with protein to produce final glycated product (AGEs). It is known to cause diabetic complications by causing damage to tissues by causing damage to or generating reactive oxygen species (ROS).

당뇨병의 치료는 일반적으로 식이요법이나 운동요법 및 약물요법 등을 병행하고 있는데, 이들 모두 지속적으로 정상 혈당을 유지시켜 당뇨합병증을 예방 또는 지연시키는 데 목표를 두고 있다. 그러나, 현재까지 당뇨합병증 등에 대한 수많은 연구가 진행되어 왔으나 아직도 완전한 치료법은 확립되어 있지 않은 실정에 있어 당뇨합병증의 치료 또는 예방과 관련된 기능성 식품이나 의약품에 대한 지속적인 연구가 절실히 요구되고 있다. Diabetes treatment is generally combined with diet, exercise therapy and drug therapy, all of which aim to prevent or delay diabetic complications by continuously maintaining normal blood sugar. However, many researches on diabetes complications have been conducted so far, but there is still a need for continuous research on functional foods and medicines related to the treatment or prevention of diabetes complications.

소나무잔나비버섯(Fomitopsis pinicola)은 우리나라 자생버섯의 일종으로 멸종된 것으로 알려져 있었으나, 최근 한 농민에 의해 발견되어 '재생버섯'으로 국립종자관리소에 등록(출원번호: 2003-498), 재배되기 시작하였다. 전기 소나무잔나비버섯은 나무줄기에 선반 모양으로 부착되어 성장하는 반원형의 대형버섯으로 윗면은 두꺼운 각피로 덮여 있어 단단하며, 표면은 밋밋하고, 흑색 또는 적갈색이다. 최근, 버섯류들이 다양한 영양소를 함유하고 있을 뿐 아니라 당뇨나 고지혈증 및 동맥경화증 등과 같은 대사성질환의 예방과 치료 및 항암, 면역증강에 관여하는 여러 종류의 생리활성물질을 함유하고 있다는 많은 연구결과들이 보고되고 있다. Fomitopsis pinicola ( Fomitopsis pinicola ) is known to be extinct as a kind of native mushroom in Korea, but recently discovered by a farmer and registered as a 'regenerated mushroom' at the National Seed Control Center (application number: 2003-498) . Electric pine grass butterfly is a semi-circular large mushroom that grows attached to a tree trunk in a shelf shape. Its top surface is covered with thick cuticles, and its surface is flat and black or reddish brown. Recently, many studies have reported that mushrooms not only contain various nutrients but also contain various kinds of bioactive substances involved in the prevention and treatment of metabolic diseases such as diabetes, hyperlipidemia and atherosclerosis, and anticancer and immune enhancement. have.

한편, 항종양에 관한 억제효과만이 알려져 있었던 소나무잔나비버섯에 대하 여, 최근에는 혈당강하 작용을 나타낸다는 보고가 있었으나(참조: 대한민국 특허공개 제 2005-60726호), 소나무잔나비버섯에 대한 생리활성 연구가 아직까지 활발히 진행되지 않는 상황이며, 구체적으로 어떠한 다당류 또는 단백다당체가 작용을 하는 지에 대해서도 정확히 밝혀지지 않은 상황이다. On the other hand, there have been reports of hypoglycemic activity against pine xanabi mushrooms, which have only been known to have anti-tumor inhibitory effects (see Korean Patent Publication No. 2005-60726). The research is not yet actively conducted, and it is not clear exactly what polysaccharide or protein polysaccharide acts.

따라서, 소나무잔나비버섯의 여러 생리활성들을 검증하고, 소나무잔나비버섯의 자실체 및 배양균사체 추출물의 제조방법의 개발 및 추출물 내의 구성 성분들을 분석하여야 할 필요성이 대두되었다. Therefore, the necessity of verifying various physiological activities of pine needles butterfly, development of a method for preparing fruiting body and culture mycelium extract of pine needles butterfly and analyzing the components in the extract has emerged.

이에, 본 발명자는 소나무잔나비버섯의 생리활성 중, 당뇨합병증을 예방 또는 지연할 수 있는 지에 대하여 알아보고자, 당뇨를 유발시킨 흰쥐에 소나무잔나비버섯의 추출물을 식이하여 관찰하던 중, 수정체 및 신장의 알도스환원효소 활성의 억제 및, 중성지질, 총 콜레스테롤 및 LDL 콜레스테롤 농도의 감소를 확인하고, 본 발명을 완성하게 되었다. 또한, 상기 소나무잔나비버섯의 추출물의 구조를 분석하여 주성분이 'β-1,3-글루카노-β-1,6-헤테로갈락토만난-단백질복합체'임을 확인하였다. Thus, the inventors of the present invention to investigate whether the physiological activity of pine zanabi mushrooms can prevent or delay diabetic complications, while dieting and observing the extract of pine zanabi mushrooms in rats that induced diabetes, Inhibition of DOS reductase activity and reduction of neutral lipid, total cholesterol and LDL cholesterol concentrations were confirmed, and the present invention was completed. In addition, by analyzing the structure of the extract of the pine zanbi mushroom, it was confirmed that the main component is 'β-1,3-glucano-β-1,6-heterogalactomannan-protein complex'.

결국, 본 발명의 주된 목적은 백내장 또는 신장병 등의 당뇨합병증과 같은 알도스환원효소의 활성증가에 기인하는 질환의 치료 또는 예방효과를 나타내는 소나무잔나비버섯 자실체 추출물 또는 배양균사체 추출물을 제공하는 것이다. After all, the main object of the present invention is to provide a pine fruit or mushroom mycelium extract exhibiting a therapeutic or prophylactic effect of a disease caused by an increase in the activity of aldose reduction enzymes such as diabetic complications such as cataracts or kidney disease.

본 발명의 다른 목적은 상기 소나무잔나비버섯 자실체 추출물 또는 배양균사체 추출물을 주재로 포함하고, 백내장 또는 신장병 등의 당뇨합병증과 같은 알도스환원효소의 활성증가에 기인하는 질환의 치료 또는 예방효과를 나타내는 조성물을 제공하는 것이다. Another object of the present invention is a composition comprising the pine berry butterfly fruit extract or culture mycelium extract as a precaution, and exhibits the treatment or prevention effect of a disease caused by the activity of aldose reduction enzymes such as diabetic complications such as cataracts or kidney disease To provide.

본 발명의 또 다른 목적은 상기 β-1,3-글루카노-β-1,6-헤테로갈락토만난-단백질복합체를 포함하고, 백내장 또는 신장병 등의 당뇨합병증과 같은 알도스환원효소의 활성증가에 기인하는 질환의 치료 또는 예방효과를 나타내는 조성물을 제공하는 것이다. Still another object of the present invention is to increase the activity of aldose-reducing enzymes, including the β-1,3-glucano-β-1,6-heterogalactomannan-protein complex, such as diabetic complications such as cataracts or kidney disease It is to provide a composition exhibiting a therapeutic or prophylactic effect of a disease caused by the.

본 발명은 소나무잔나비버섯(Fomitopsis pinicola) 자실체 추출물 또는 배양균사체 추출물을 포함하는, 알도스환원효소의 활성증가에 기인하는 질환, 예를 들어, 당뇨합병증의 치료 또는 예방을 위한 조성물을 제공한다.The present invention is a pine grass butterfly ( Fomitopsis) pinicola ) provides a composition for the treatment or prevention of diseases caused by increased activity of aldose reductase, including fruiting body extract or culture mycelia extract, for example, diabetic complications.

소나무잔나비버섯의 자실체 추출물은 열수추출물 또는 알칼리추출물이며, 열수추출물은 소나무잔나비버섯 자실체를 세절, 파쇄, 가수 및 가열하여 추출한 다음, 이를 농축하여 에탄올로 침전시키고, 전기 침전물을 동결건조하는 방법으로 수득한다. 이때, 가수는 특별히 이에 제한되지는 않으나, 파쇄된 자실체 중량의 약 30배 중량에 해당되는 정제수를 가하는 것이 바람직하고, 추출은 특별히 이에 제한 되지는 않으나, 100℃에서 약 24시간 추출하는 것이 바람직하며, 농축은 특별히 이에 제한되지는 않으나, 40℃에서 초기부피의 약 1/10이 될 때까지 농축하는 것이 바람직하다. The fruiting body extract of pine needles butterfly is a hot water extract or an alkali extract, and the hot water extract is extracted by cutting, crushing, watering and heating the pine fruit butterfly, which is concentrated and precipitated with ethanol, and the precipitate is obtained by freeze drying. do. In this case, the valence is not particularly limited thereto, but it is preferable to add purified water corresponding to about 30 times the weight of the crushed fruiting body, and the extraction is not particularly limited, but it is preferable to extract at about 24 hours at 100 ° C. However, the concentration is not particularly limited, but it is preferable to concentrate at 40 ° C. until it is about 1/10 of the initial volume.

또한, 알칼리추출물은 소나무잔나비버섯 자실체를 세절 및 파쇄하고 이를 1N KOH로 1시간 동안 팽윤시킨 후, 파쇄기를 사용하여 균질화하며, 100mesh 체로 여과하고, 진한염산으로 중화 및 증류수로 세척한 후, 60℃에서 건조하는 방법으로 수득한다. 이때, 팽윤은 특별히 이에 제한되지는 않으나, 1N KOH를 약 1:1(w/v)로 가하여 팽윤시키는 것이 바람직하다. 이러한 알칼리추출법은 종래의 알칼리추출법에 비하여 수율을 획기적으로 개선시킨 것으로서, HAS(homogenization after alkali swelling) 법으로도 불린다.In addition, the alkaline extracts are chopped and crushed pine needles mushroom fruit body and swelled with 1N KOH for 1 hour, homogenized using a crusher, filtered through a 100mesh sieve, neutralized with concentrated hydrochloric acid and washed with distilled water, 60 ℃ Obtained by drying in the. At this time, the swelling is not particularly limited, but it is preferable to swell by adding 1N KOH at about 1: 1 (w / v). The alkali extraction method is a drastically improved yield compared to the conventional alkali extraction method, also called a HAS (homogenization after alkali swelling) method.

한편, 소나무잔나비버섯의 배양균사체 추출물은 소나무잔나비버섯의 균사체 종균을 계대배양 및 종균배양한 후, 살균 및 냉각한 감자배지에 접종하여 배양하고, 배양이 종료된 배양액을 중화 및 에탄올 침전시킨 후, 전기 침전물을 증류수로 투석하는 방법으로 수득한다. 이때, 배양액의 중화는 특별히 이에 제한되지는 않으나, 중조(NaHCO3)로 pH 6.5까지 중화시키는 것이 바람직하다.On the other hand, the culture mycelium extract of pine zanbi mushroom is cultured by subculture and seed culture of the mycelia of pine zanbi mushroom, and then inoculated in sterilized and cooled potato medium, and cultured by neutralization and ethanol precipitation, The precipitate is obtained by dialysis with distilled water. At this time, the neutralization of the culture solution is not particularly limited thereto, but neutralizing to pH 6.5 with a sodium bicarbonate (NaHCO 3 ).

본 발명에서 알도스환원효소의 활성증가에 기인하는 질환이라 함은 백내장 또는 신장병 등과 같은 당뇨합병증을 포함하는 질환을 의미한다. 알도스환원효소에 의하여 포도당이 솔비톨로 대사되고, 생성된 솔비톨은 세포막 투과도가 낮아 삼 투압 스트레스를 야기시켜 수정체, 망막 또는 신장의 사구체와 같은 기관들의 손상을 초래한다(참조: 도 1). In the present invention, the disease caused by the increased activity of aldose reductase means a disease including diabetic complications such as cataract or kidney disease. Glucose is metabolized by aldose-reductase to sorbitol, and the resulting sorbitol has low cell membrane permeability, causing osmotic stress, resulting in damage to organs such as glomeruli of the lens, retina or kidney (see FIG. 1).

상기 방법으로부터 수득한 본 발명 소나무잔나비버섯 추출물의 알도스환원효소 활성증가에 기인하는 질환, 예를 들어, 당뇨합병증의 예방효과 또는 당뇨 유도성 고콜레스테롤혈증 개선효과를 하기와 같이 조사하였다. STZ(streptozotocin)로 당뇨를 유발한 흰쥐에 상기 추출물을 경구투여하여 사육시킨 후, 실험쥐로부터 수정체와 신장을 적출하여 빙냉하에서 균질화하고, 상기 균질화된 수정체 및 신장으로부터 알도스환원효소의 활성을 조사하여 당뇨합병증 예방효과를 확인하였으며, 또한, 실험쥐로부터 혈액을 얻고 상기 혈액을 분석하여 트리글리세라이드, 총 콜레스테롤, HDL 콜레스테롤 및 LDL 콜레스테롤 함량을 조사하여 당뇨 유도성 고콜레스테롤혈증 개선효과를 확인하였다.The disease caused by the increase of aldose reductase activity of the present invention pine zanbi mushroom extract obtained from the above method, for example, the prevention effect of diabetic complications or diabetic induced hypercholesterolemia improvement effect was investigated as follows. After the oral administration of the extract to rats induced diabetes with STZ (streptozotocin), the lens and kidney were extracted from the mice, homogenized under ice-cooling, and the activity of aldose reductase from the homogenized lens and kidney was investigated. The diabetic complications were prevented, and blood was obtained from the mice, and the blood was analyzed to examine triglyceride, total cholesterol, HDL cholesterol, and LDL cholesterol content to confirm the effect of improving diabetes-induced hypercholesterolemia.

나아가, 본 발명 소나무잔나비버섯 추출물의 상기 효과를 가져오는 활성원을 알아보기 위하여, DEAE-셀룰로즈 이온교환수지와 세파로즈 CL-4B 겔 여과용 컬럼을 이용하여 순차적으로 분획, 정제한 후, GC를 이용하여 메틸화 분석을 수행하여 소나무잔나비버섯 추출물의 구성성분 및 분자량을 확인하였다. Furthermore, in order to find out the active source of the above-mentioned effect of pine needles mushroom extract of the present invention, using a DEAE-cellulose ion exchange resin and Sepharose CL-4B gel filtration column sequentially fractionated, purified, GC Methylation analysis was carried out to determine the composition and molecular weight of the pine needles mushroom extract.

이하, 본 발명의 구체적인 방법을 실시예를 들어 상세히 설명하고자 하지만, 본 발명의 권리범위는 이들 실시예에만 한정되는 것은 아니다.Hereinafter, the specific method of the present invention will be described in detail with reference to Examples, but the scope of the present invention is not limited only to these Examples.

실시예Example

실시예 1: 소나무잔나비버섯의 자실체 추출물 및 배양균사체 추출물 제조 Example 1 Preparation of Fruiting Body Extract and Cultured Mycelia Extract of Pine Sprout Butterfly

실시예 1-1: 소나무잔나비버섯의 자실체 열수추출물 제조 Example 1-1 : Preparation of fruiting body hot water extract of pine tree butterfly

포항시 소재 재생농산으로부터 제공받은 소나무잔나비버섯 자실체 90g을 5×5mm로 세절하고, 파쇄한 후, 정제수 2.5L를 가하고 이를 100℃에서 24시간 동안 추출하였다. 그 후, 40℃에서 추출액이 250mL 될 때까지 농축하고, 에탄올을 가하여 침전시켜, 알콜불용성물질을 수득하였다. 전기 침전된 알콜불용성물질을 동결건조하여 소나무잔나비버섯 자실체 열수추출물을 수득하였다. 90 g of pine berry butterfly fruit body provided from regenerated agricultural products in Pohang was cut into 5 × 5 mm, crushed, 2.5L of purified water was added thereto, and extracted at 100 ° C. for 24 hours. Thereafter, the extract was concentrated to 40 mL at 40 ° C, and precipitated by addition of ethanol to obtain an alcohol insoluble substance. The precipitated alcohol-insoluble substance was lyophilized to obtain pine needles mushroom fruiting hot water extract.

실시예 1-2: 소나무잔나비버섯의 자실체 알칼리추출물 제조 Example 1-2 Preparation of Fruiting Body Alkali Extracts of Pine Turtle Butterfly

포항시 소재 재생농산으로부터 제공받은 소나무잔나비버섯 자실체 90g을 5×5mm로 세절 및 파쇄하고 이를 1N KOH(1:1, w/v)로 1시간 동안 팽윤시킨 후, 파쇄기를 사용하여 균질화하였다. 그 후, 100mesh 체로 여과하고, 진한염산으로 중화하였으며, 증류수로 세척한 후, 60℃에서 건조시켜 소나무잔나비버섯의 자실체 알칼리추출물을 수득하였다. 90 g of pine berry butterfly fruit body provided from regenerated agricultural products in Pohang was cut into 5 × 5 mm and crushed and swelled with 1N KOH (1: 1, w / v) for 1 hour, and then homogenized using a crusher. Thereafter, the resultant was filtered through a 100mesh sieve, neutralized with concentrated hydrochloric acid, washed with distilled water, and dried at 60 ° C. to obtain a fruiting body alkali extract of pine needles butterfly.

실시예 1-3: 소나무잔나비버섯의 배양균사체 추출물 제조 Example 1-3 Preparation of Cultured Mycelium Extract of Pine Turtle Butterfly

포항시 소재 재생농산으로부터 분주받은 소나무잔나비버섯의 균사체 종균을 YM 아가배지(효모추출물: 0.5%(w/v), 펩톤: 0.5%(w/v), 맥아추출물: 0.2%(w/v), 포도당: 1.0%(v/v), 아가: 2.0%(w/v), pH 6.5)에 접종하고, 30℃에서 15일마다 계대배양한 후, 상기 배양액을 YM 배지를 사용하여 회전식진탕기(150rpm)에서 종균배양하였다. The mycelium spawns of pine beetle mushrooms from Pohang-si regenerated farms were collected in YM agar medium (yeast extract: 0.5% (w / v), peptone: 0.5% (w / v), malt extract: 0.2% (w / v), Glucose: 1.0% (v / v), agar: 2.0% (w / v), pH 6.5), and subcultured every 15 days at 30 ℃, the culture medium using a rotary shaker (YM medium) Spawn at 150 rpm).

상기 배양 10일 후, 상기 배양액을 살균(120℃, 30분), 냉각한 감자배지(물: 16L, 감자분말: 300g, 설탕: 150g, 펩톤: 0.1g)에 2%(v/v) 되도록 접종하고, 150rpm, 30℃ 조건의 회전식 진탕기에서 살균공기를 주입(10cm3/min)하면서 10일간 균사체 액체배양한 후, 중조(NaHCO3)로 pH 6.5까지 중화시키고 10배량의 에탄올을 가하여 침전시켰다. After 10 days of incubation, the culture solution was sterilized (120 ° C., 30 minutes) and cooled to 2% (v / v) in potato medium (water: 16L, potato powder: 300g, sugar: 150g, peptone: 0.1g). Inoculated, incubated with mycelium liquid for 10 days while injecting sterilization air (10cm 3 / min) in a rotary shaker at 150rpm, 30 ℃, neutralized to pH 6.5 with sodium bicarbonate (NaHCO 3 ) and precipitated by adding 10-fold ethanol I was.

상기에서 얻은 침전물을 분자량 3,000 이하를 제거시키는 투석막을 이용하여 48시간 동안 증류수로 투석하여 소나무잔나비버섯 배양균사체 추출물을 수득하였다. The precipitate obtained above was dialyzed with distilled water for 48 hours using a dialysis membrane to remove molecular weight 3,000 or less to obtain a pine myrtle mushroom culture mycelium extract.

실시예 2: 소나무잔나비버섯 추출물의 당뇨합병증 예방효과 Example 2 : Prevention of Diabetic Complications of Pine Barberry Butterfly Extract

실시예 2-1: 실험군 및 실험방법 Example 2-1 : Experimental group and test method

체중 200±5g 내외의 SD계 숫 흰쥐를 정상 대조군(NC), 당뇨 대조군(DM), 당뇨유발 후 열수추출물 1% 첨가식이군(DM-WE), 당뇨유발 후 알칼리추출물 1% 첨가식이군(DM-AE) 및 당뇨유발 후 배양균사체 추출물 1% 첨가식이군(DM-CM) 등 5군으로 분류하였고, 각 군은 7마리씩으로 하여 표 1의 식이조성표에 따라 4주간 성장시켰다. 당뇨유발은 STZ(streptozotocin, 55mg/kg)를 근육주사 하였으며, STZ 투여 48시간 후에 혈당을 측정하여 300mg/dL 이상인 동물을 당뇨유발 모델 실험동물로 간주하고 실험에 이용하였다. 혈당은 Bio-sensor와 kit 시약을 이용하여 측정하였다. SD male rats with a body weight of 200 ± 5g were fed the normal control group (NC), the diabetic control group (DM), 1% supplemented hot water extract after diabetic induction (DM-WE), and 1% added alkaline extract after diabetic induction ( DM-AE) and after the induction of diabetes were classified into 5 groups, such as dietary mycelial extract 1% diet group (DM-CM), each group was grown to four weeks according to the dietary composition of Table 1. Diabetes induced STZ (streptozotocin, 55mg / kg) was injected intramuscularly, and blood glucose was measured 48 hours after STZ administration, and animals over 300mg / dL were regarded as diabetes-induced model experimental animals and used in the experiment. Blood glucose was measured using Bio-sensor and kit reagent.

표 1: 동물실험을 위한 기본식이조성(g/kg) Table 1 : Basic Dietary Composition for Animal Experiments (g / kg)

식이조성Diet NC (정상군)NC (normal group) WE (열수추출물군)WE (Hot Water Extract Group) AE (알칼리추출물군)AE (alkali extract group) CM (균사체배양액군)CM (mycelium culture group) 카제인Casein 200200 200200 200200 200200 콘스타치cornstarch 150150 150150 150150 150150 설탕Sugar 500500 500500 500500 500500 셀룰로즈Cellulose 5050 4040 4040 4040 콘오일Corn oil 5050 5050 5050 5050 AIN-미네랄믹스쳐1 ) AIN-mineral mix 1 ) 3535 3535 3535 3535 AIN-비타민믹스쳐2 ) AIN-Vitamin Mixture 2 ) 1010 1010 1010 1010 DL-메티오닌DL-Methionine 33 33 33 33 콜린바이타타레이트Cholinevitatarate 22 22 22 22 자실체열수추출물Fruiting water extract -- 1010 -- -- 자실체알칼리추출물Fruiting body alkali extract -- -- 1010 -- 균사체배양액추출물Mycelial Culture Extract -- -- -- 1010 총합    total 1,0001,000 1,0001,000 1,0001,000 1,0001,000

1)AIN-미네랄믹스쳐(g/kg): 젖산칼슘 620.0, 염화나트륨 74.0, 제2인산칼륨 220.0, 황산칼륨 52.0, 산화마그네슘 23.0, 아망간산카보네이트 3.3, 구연산철 6.0, 탄산아연 1.0, 탄산구리 0.2, 요오드산칼륨 0.01, 소듐셀레나이트 0.01 및 황산크롬칼륨 0.5를 미세한 분말로 하여 1,000g 제조 1) AIN-mineral mixture (g / kg): calcium lactate 620.0, sodium chloride 74.0, potassium diphosphate 220.0, potassium sulfate 52.0, magnesium oxide 23.0, manganese carbonate 3.3, iron citrate 6.0, zinc carbonate 1.0, copper carbonate 0.2 , 1,000 g of potassium iodide 0.01, sodium selenite 0.01 and potassium chromium sulfate 0.5 as fine powder

2)AIN-비타민믹스쳐(mg/kg): 염산티아민 600, 리보플라빈 600, 염산피리독신 700, 니코틴산 3,000, D-판토텐산칼슘 1,600, 엽산 200, D-비오틴 20, 비타민 B12 2.5, 비타민 A 400,000 IU, 비타민 D3 100,000 IU, 비타민 E 7,500 IU 및 비타민 K 75를 미세한 분말로 하여 1,000g 제조 2) AIN-vitamin mixture (mg / kg): Thiamine hydrochloride 600, Riboflavin 600, Pyridoxine hydrochloride 700, Nicotinic acid 3,000, D-calcium pantothenate 1,600, Folic acid 200, D-biotin 20, Vitamin B12 2.5, Vitamin A 400,000 IU, 1,000 g of Vitamin D3 100,000 IU, Vitamin E 7,500 IU and Vitamin K 75 as fine powder

또한, 식이를 달리하여 4주간 성장시키는 동안 실험동물의 증체량, 식이섭취량 및 식이효율을 관찰하였다(참조: 표 2). 당뇨 대조군인 DM군의 증체량과 식이효율은 정상 대조군인 NC군에 비해 현저히 감소하였다. 그러나, 소나무잔나비버섯 자실체 알칼리추출물 1% 첨가식이군에서는 NC군에 비하여 감소하였지만, DM군에 비해서는 유의한 증가를 나타내었다. 식이섭취량은 DM군과 열수추출물 및 배양균사체 추출물 첨가식이군에서 NC군에 비하여 현저히 증가하였으나, 알칼리추출물 첨가식이군에서는 대조군 수준으로 회복되었다. 식이효율은 모든 실험식이군에서 NC군에 비하여 현저히 감소하였으나, 당뇨대조군에 비해서는 모든 소나무잔나비버섯 추출물 첨가식이군에서 증가하였다.In addition, the weight gain, dietary intake and dietary efficiency of the experimental animals were observed during four weeks of growth by varying the diet (see Table 2). The weight gain and dietary efficiency of the DM group, the diabetic control group, were significantly reduced compared to the NC group. However, in the diet group added 1% of pine needles fruiting body alkali extract, it decreased compared to NC group, but showed a significant increase compared to DM group. The dietary intake was significantly increased in the DM group, the hot water extract, and the cultured mycelial extract group compared with the NC group, but was restored to the control level in the alkaline extract group. Dietary efficiency was significantly decreased in all experimental diet groups compared to NC group, but increased in all pine needles extracts compared to diabetic control group.

표 2: STZ로 당뇨유발한 쥐의 증체량, 식이섭취량 및 식이효율에 미치는 소나무잔나비버섯 추출물들의 4주간 급여 효과 Table 2 : Feeding Effect of Pine Bark Butterfly Extracts on the Weight Gain, Dietary Intake and Dietary Efficiency of STZ-induced Diabetic Rats for 4 Weeks

그룹1 ) Group 1 ) 최종체중(g)Final weight (g) 증체량 (g/week)Weight gain (g / week) 식이섭취량 (g/week)Dietary Intake (g / week) 식이효율2 ) Dietary Efficiency 2 ) NC NC 315.8±7.08315.8 ± 7.08 28.96±5.8828.96 ± 5.88 175.1±5.4175.1 ± 5.4 0.165±0.0060.165 ± 0.006 DM DM 172.8±22.6172.8 ± 22.6 -6.79±2.54-6.79 ± 2.54 206.5±11.2206.5 ± 11.2 -0.033±0.034-0.033 ± 0.034 DM-WE DM-WE 203.8±32.3203.8 ± 32.3 0.95±7.210.95 ± 7.21 199.8±10.3199.8 ± 10.3 0.005±0.0280.005 ± 0.028 DM-AE DM-AE 260.2±21.4260.2 ± 21.4 15.06±6.1115.06 ± 6.11 179.5±6.2179.5 ± 6.2 0.084±0.0190.084 ± 0.019 DM-CM DM-CM 193.9±17.1193.9 ± 17.1 -1.51±7.03-1.51 ± 7.03 198.6±8.7198.6 ± 8.7 0.008±0.0310.008 ± 0.031

1)NC: 정상 대조군, DM: 당뇨 대조군, DM-WE: STZ 처치 후 소나무잔나비버섯 자실체 열수추출물 1% 첨가식이군, DM-AE: STZ 처치 후 소나무잔나비버섯 자실체 알칼리추출물 1% 첨가식이군, DM-CM: STZ 처치 후 소나무잔나비버섯 배양균사체 추출물 1% 첨가식이군 1) NC: normal control group, DM: diabetic control group, DM-WE: dietary supplementation of 1% pine needles mushroom fruiting hot water extract after STZ treatment, DM-AE: dietary supplementation of 1% pine needles fruiting body alkali extract after STZ treatment, DM-CM: Addition of 1% of pine myrtle mushroom culture mycelium extract after STZ treatment

2)식이효율(feed efficiency ratio): 증체량/식이섭취량 2) feed efficiency ratio: weight gain / food intake

실험식이로 4주간의 동물실험이 끝난 쥐를 16시간 동안 물만 주고 절식시킨 후, 에테르 마취 하에서 복부정중선을 따라 개복한 다음, 복부대동맥으로부터 혈액을 채취하여 혈당을 분석하고 신장과 안구의 수정체를 적출하여 빙냉하에서 균질기로 균질화하여 postmitochondria 분획을 얻고, 이를 알도스환원효소(aldose reductase: AR)의 활성을 알아보기 위한 효소용액으로 사용하였다.After four weeks of animal experiments, the rats were fasted with water for 16 hours, and then opened through the abdominal midline under ether anesthesia, blood was collected from the abdominal aorta, blood glucose was analyzed, and kidney and eye lenses were extracted. By homogenizing with a homogenizer under ice-cooling to obtain a postmitochondria fraction, it was used as an enzyme solution to determine the activity of aldose reductase (AR).

실시예 2-2: 소나무잔나비버섯 추출물의 당뇨합병증 예방효과 Example 2-2 : Prevention of Diabetic Complications of Pine Needle Butterfly Extract

당뇨에 의해 유발되는 백내장이나 말초신경염 및 신장 손상 등과 같은 합병증은 정상적인 당질의 주 대사과정인 혐기적 해당과정의 첫단계 효소인 헥소키나아제가 고혈당에 의해 포화되어 당질의 부 대사과정인 폴리올 경로로 대사됨으로써 발생하는 것으로 알려져 있다. 폴리올 경로의 첫단계 효소인 알도스환원효소를 통해 포도당이 환원되어 생성된 솔비톨은 세포막 투과성이 낮은 물질로 과잉으로 생성된 솔비톨에 의해 조직 세포 내로 과잉의 수분이 유입되어 인슐린 비의존성 장기인 수정체나 말초신경 및 신장의 손상이 유발되는 것으로 보고되고 있으며, 상기와 같은 장기들의 알도스환원효소의 활성을 억제하는 물질은 당뇨합병증을 예방 또는 지연시키는 것으로 알려져 있다. Complications such as cataracts, peripheral neuritis, and kidney damage caused by diabetes are hemokinase, the first enzyme in anaerobic glycolysis, the main metabolic process of normal sugars, and is metabolized by the polyol pathway, which is the metabolic process of sugars. It is known to occur by. Sorbitol, produced by reducing glucose through aldose-reductase, the first stage of the polyol pathway, is a substance with low cell membrane permeability. It has been reported to cause peripheral nerve and kidney damage, and substances that inhibit the activity of aldose reductase in such organs are known to prevent or delay diabetic complications.

따라서, 실시예 2-1에 의하여 준비된 수정체 및 신장 각각의 효소용액 내의 알도스환원효소의 활성을 측정함으로써, 본 발명의 소나무잔나비버섯 추출물의 당뇨합병증 예방효과를 알아보고자 하였다.Therefore, by measuring the activity of the aldose reductase in the enzyme solution of each of the lens and kidney prepared in Example 2-1, it was to investigate the diabetic complication prevention effect of pine needles mushroom extract of the present invention.

알도스환원효소 활성은 Hayman과 Kinoshita의 방법(1965)에 따라 50mM 인산완충액(pH 6.2) 일정량에 황산리튬, NADPH, DL-α-글리세롤 및 효소액을 가하여 25℃에서 반응시키는 동안 감소하는 NADPH의 함량을 340nm에서 측정하였다. The aldose-reducing enzyme activity was reduced by the addition of lithium sulfate, NADPH, DL-α-glycerol and enzyme solution to 50mM phosphate buffer (pH 6.2) according to the method of Hayman and Kinoshita (1965). Was measured at 340 nm.

실시예 2-2-1: 수정체의 알도스환원효소 활성 억제효과 Example 2-2-1 : Inhibitory Effect of the Lens on Aldose Reductase Activity

흰쥐의 수정체 마쇄 균질액을 원심분리하여 나온 postmitochondria 분획을 효소원으로 하여 소나무잔나비버섯 자실체로부터 열수추출한 추출물을 시험관 내에 첨가하면서 알도스환원효소의 활성변화를 관찰한 결과를 도 2 및 도 3에 나타내었다. 자실체의 열수추출물의 첨가 농도에 비례하여 알도스환원효소의 활성이 감소하였으며, 125㎍/mL의 첨가농도에서는 대조구에 비해 약 50% 가까이 효소의 활성이 현저히 억제되었다. 한편, 소나무잔나비버섯 자실체 추출물 첨가에 의한 알도스환원효소의 활성 억제현상이 어떠한 작용에 의해 나타나는 지를 동력학적인 측면에서 관찰하였을 때, Vmax치는 별다른 변동이 없었으나 km치가 현저히 증가하였다. The results of observing the activity change of aldose-reducing enzyme were added to the test tube by adding the hot-water extract from pine fruit butterfly, fruiting body, as a enzyme source, using the postmitochondria fraction obtained by centrifugation of the pulverized lens homogenate of rats in FIGS. It was. The activity of aldose-reducing enzyme was decreased in proportion to the concentration of hot water extract of fruiting body, and the activity of enzyme was significantly inhibited by about 50% compared to the control at the concentration of 125 ㎍ / mL. On the other hand, when the kinetics of the action of activating the aldose-reducing enzyme activity by the addition of pine needles fruiting body extract was observed, the Vmax value was not significantly changed, but the km value increased significantly.

실시예 2-2-2: 신장의 알도스환원효소 활성 감소효과 Example 2-2-2 : effect of reducing aldose reductase activity of kidney

흰쥐의 신장 마쇄 균질액을 원심분리하여 나온 postmitochondria 분획을 효소원으로 하여 각 경우에 있어서 알도스환원효소(AR)의 활성변동을 알아보았다. STZ 투여에 의한 당뇨 대조군(DM)의 경우 정상 대조군(NC)에 비하여 알도스환원효소의 활성이 약 47% 증가하였으며, 소나무잔나비버섯 자실체의 알칼리추출물(AE)을 첨가한 식이군에서는 당뇨 대조군에 비하여 약 25% 감소하였고, 자실체의 열수추출물(WE) 및 배양균사체 추출물(CM)을 첨가한 식이군에서도 감소하는 경향을 나타내었다(참조: 표 3). The activity of aldose-reducing enzyme (AR) was investigated in each case using the postmitochondria fraction obtained by centrifugation of the kidney ground homogenate of rats as an enzyme source. In the diabetic control group (DM) by STZ administration, the activity of aldose-reducing enzyme was increased by about 47% compared to the normal control group (NC). Compared with the decrease of about 25%, dietary group containing the hot water extract (WE) and culture mycelia extract (CM) of the fruiting body showed a tendency to decrease (see Table 3).

표 3: STZ로 당뇨유발한 흰쥐의 신장조직 알도스환원효소(AR)의 활성변동에 미치는 각 소나무잔나비버섯 추출물의 4주간 급여효과 Table 3 : Feeding Effects of Four Pine Butterflies Extracts on the Activity Changes of Renal Tissue Aldose Reductase (AR) in STZ-Induced Diabetic Rats

그룹1 ) Group 1 ) AR활성 (산화된 NADPH nmoles/mg protein/min)AR activity (oxidized NADPH nmoles / mg protein / min) NC NC 4.89±0.714.89 ± 0.71 DM DM 7.17±0.877.17 ± 0.87 DM-WE DM-WE 6.27±0.936.27 ± 0.93 DM-AE DM-AE 5.36±0.865.36 ± 0.86 DM-CM DM-CM 6.39±0.806.39 ± 0.80

1)NC: 정상 대조군, DM: 당뇨 대조군, DM-WE: 당뇨유발후 소나무잔나비버섯 자실체 열수추출물 1% 첨가식이군, DM-AE: 당뇨유발후 소나무잔나비버섯 자실체 알칼리추출물 1% 첨가식이군, DM-CM: 당뇨유발후 소나무잔나비버섯 배양균사체 추출물 1% 첨가식이군 1) NC: Normal control group, DM: Diabetic control group, DM-WE: Dietary supplementation of pine needle butterfly fruit fruit hot water extract after diabetes induction, DM-AE: Dietary addition of pine needle butterfly fruit fruit alkali extract after diabetes induction, DM-CM: Addition of 1% of pine myrtle mushroom culture mycelium extract after diabetes induction

실시예 3: 소나무잔나비버섯 추출물의 당뇨 유도성 고콜레스테롤혈증 개선효과 Example 3 Diabetes Induction Hypercholesterolemia Improvement Effect of Pine Bark Butterfly Extract

실험군 및 식이투여방법은 모두 실시예 2와 동일하며, 5개 실험군을 4주간 식이투여하여 혈청 트리글리세라이드, 총 콜레스테롤, LDL 콜레스테롤 및 HDL 콜레스테롤 함량을 측정하였다. 혈청 트리글리세라이드, 총 콜레스테롤 및 HDL 콜레스테롤 함량은 시중에서 구입한 kit 시약(AM 157S-K, AM 202-K, AM 203-K, Asanpharm Co., Korea)을 이용하여 측정하였으며, LDL 콜레스테롤 함량은 Fridwell 등(1972)의 방법에 따라 계산하였다. Both the experimental group and the dietary administration method were the same as in Example 2, and the five experimental groups were fed for four weeks to measure serum triglyceride, total cholesterol, LDL cholesterol and HDL cholesterol content. Serum triglycerides, total cholesterol and HDL cholesterol content were measured using commercially available kit reagents (AM 157S-K, AM 202-K, AM 203-K, Asanpharm Co., Korea), and LDL cholesterol content was Fridwell. (1972).

혈청 트리글리세라이드의 함량은 정상 대조군에 비해 STZ를 투여한 당뇨 대조군에서 유의하게 증가하였으나, 소나무잔나비버섯 자실체 알칼리추출물 1%(w/w) 첨가식이군은 정상 대조군 수준으로 회복되었다. 그러나, 소나무잔나비버섯 자실체 열수추출물 1%(w/w) 첨가식이군 및 배양균사체 추출물 1%(w/w) 첨가식이군에서는 당뇨 대조군과 유사하게 나타났다(참조: 표 4).Serum triglyceride content was significantly increased in the diabetic control group treated with STZ compared to the normal control group, but the dietary group containing 1% (w / w) pine needles mushroom fruit alkali extract returned to the normal control level. However, in the diet group added 1% (w / w) of pine needles fruiting body fruit hot water extract and the culture group added 1% (w / w) of mycelial extract were similar to the diabetic control (see Table 4).

표 4: STZ로 유발한 당뇨흰쥐의 혈청 중성지질함량에 미치는 소나무잔나비버섯 추출물의 4주간 급여효과 Table 4 : Feeding Effect of Pine Bark Butterfly Extract for 4 Weeks on Serum Neutral Lipid Content of STZ-induced Diabetic Rats

그룹1 ) Group 1 ) 혈청중성지질(mg/dL)Serum triglyceride (mg / dL) NC NC 98.5±15.298.5 ± 15.2 DM DM 128.7±13.0128.7 ± 13.0 DM-WE DM-WE 126.8±15.6126.8 ± 15.6 DM-AE DM-AE 112.9±14.1112.9 ± 14.1 DM-CM DM-CM 123.6±14.4123.6 ± 14.4

1)NC: 정상 대조군, DM: 당뇨 대조군, DM-WE: 당뇨유발후 소나무잔나비버섯 자실체 열수추출물 1% 첨가식이군, DM-AE: 당뇨유발후 소나무잔나비버섯 자실체 알칼리추출물 1% 첨가식이군, DM-CM: 당뇨유발후 소나무잔나비버섯 배양균사체 추출물 1% 첨가식이군 1) NC: Normal control group, DM: Diabetic control group, DM-WE: Dietary supplementation of pine needle butterfly fruit fruit hot water extract after diabetes induction, DM-AE: Dietary addition of pine needle butterfly fruit fruit alkali extract after diabetes induction, DM-CM: Addition of 1% of pine myrtle mushroom culture mycelium extract after diabetes induction

또한, 혈청 총 콜레스테롤의 함량은 당뇨 대조군에 비하여 소나무잔나비버섯 자실체 알칼리추출물 1%(w/w) 첨가식이군에서는 18% 정도 감소하였으나, 열수추출물 및 배양균사체 추출물 첨가식이군에서는 유의성은 없었으나 감소하는 경향을 나타내었다(참조: 표 5).In addition, the serum total cholesterol content was decreased by 18% in the diet group containing 1% (w / w) pine needles fruit fruit alkali extract compared to the diabetic control group, but it was not significantly decreased in the diet group containing the hot water extract and culture mycelia extract. (Table 5).

표 5: STZ로 유발한 당뇨흰쥐의 혈청 총 콜레스테롤함량에 미치는 소나무잔 나비버섯 추출물의 4주간 급여효과 Table 5 : Dietary Effect of Pine Stem Butterfly Mushroom Extracts on Serum Total Cholesterol Content in Diabetic Rats Induced by STZ for 4 Weeks

그룹1 ) Group 1 ) 혈청 총 콜레스테롤(mg/dL)Serum Total Cholesterol (mg / dL) NC NC 107.0±11.2107.0 ± 11.2 DM  DM 142.8±16.3142.8 ± 16.3 DM-WE DM-WE 134.5±22.1134.5 ± 22.1 DM-AE DM-AE 117.8±12.5117.8 ± 12.5 DM-CM DM-CM 125.1±20.4125.1 ± 20.4

1)NC: 정상 대조군, DM: 당뇨 대조군, DM-WE: 당뇨유발후 소나무잔나비버섯 자실체 열수추출물 1% 첨가식이군, DM-AE: 당뇨유발후 소나무잔나비버섯 자실체 알칼리추출물 1% 첨가식이군, DM-CM: 당뇨유발후 소나무잔나비버섯 배양균사체 추출물 1% 첨가식이군 1) NC: Normal control group, DM: Diabetic control group, DM-WE: Dietary supplementation of pine needle butterfly fruit fruit hot water extract after diabetes induction, DM-AE: Dietary addition of pine needle butterfly fruit fruit alkali extract after diabetes induction, DM-CM: Addition of 1% of pine myrtle mushroom culture mycelium extract after diabetes induction

한편, LDL 콜레스테롤 함량은 STZ 투여에 의해 당뇨 대조군에서는 정상 대조군에 비하여 약 95% 현저히 증가하였고, 소나무잔나비버섯 자실체 알칼리추출물 1%(w/w) 첨가식이군에서는 당뇨 대조군에 비하여 유의하게 감소하여 정상 대조구 수준으로 회복되었고, 배양균사체 추출물 1%(w/w) 첨가식이군에서도 당뇨 대조군에 비하여 유의하게 감소하였으나, 열수추출물 1%(w/w) 첨가식이군에서는 유의성은 없었으나 감소하는 경향을 나타내었다(참조: 표 6). On the other hand, LDL cholesterol content was significantly increased by 95% in the diabetic control group compared to the normal control group by STZ administration, and significantly decreased compared to the diabetic control group in the diet group containing 1% (w / w) pine needles and fruit body alkali extracts. The control group was restored to control level and significantly decreased in the diet group containing 1% (w / w) cultured mycelia extract compared to the diabetic control group, but not significantly decreased in the diet group with 1% (w / w) of hot water extract. (Table 6).

표 6: STZ로 유발한 당뇨흰쥐의 혈청 LDL 콜레스테롤 함량에 미치는 소나무잔나비버섯 추출물의 4주간 급여효과 Table 6 : Supplemental Effect of Pine Bark Butterfly Extract for 4 Weeks on Serum LDL Cholesterol Content in STZ-Induced Diabetic Rats

그룹1 ) Group 1 ) 혈청 LDL 콜레스테롤(mg/dL)Serum LDL Cholesterol (mg / dL) NC NC 34.9±5.734.9 ± 5.7 DM  DM 68.2±12.368.2 ± 12.3 DM-WE DM-WE 57.5±11.857.5 ± 11.8 DM-AE DM-AE 39.7±9.739.7 ± 9.7 DM-CM DM-CM 47.1±11.247.1 ± 11.2

1)NC: 정상 대조군, DM: 당뇨 대조군, DM-WE: 당뇨유발후 소나무잔나비버섯 자실체 열수추출물 1% 첨가식이군, DM-AE: 당뇨유발후 소나무잔나비버섯 자실체 알칼리추출물 1% 첨가식이군, DM-CM: 당뇨유발후 소나무잔나비버섯 배양균사체 추출물 1% 첨가식이군 1) NC: Normal control group, DM: Diabetic control group, DM-WE: Dietary supplementation of pine needle butterfly fruit fruit hot water extract after diabetes induction, DM-AE: Dietary addition of pine needle butterfly fruit fruit alkali extract after diabetes induction, DM-CM: Addition of 1% of pine myrtle mushroom culture mycelium extract after diabetes induction

그러나, 혈청 HDL 콜레스테롤 함량은 모든 실험군에서 당뇨 대조군에 비하여 증가하였으나 유의성은 없었다(참조: 표 7).However, serum HDL cholesterol content was increased in all experimental groups compared to the diabetic control group, but was not significant (Table 7).

표 7: STZ로 유발한 당뇨흰쥐의 혈청 HDL 콜레스테롤 함량에 미치는 소나무잔나비버섯 추출물의 4주간 급여효과 Table 7 : Feeding Effect of Pine Bark Butterfly Extract for 4 Weeks on Serum HDL Cholesterol Content in STZ-Induced Diabetic Rats

그룹1 ) Group 1 ) 혈청 HDL 콜레스테롤(mg/dL)Serum HDL Cholesterol (mg / dL) NC NC 52.4±5.852.4 ± 5.8 DM  DM 48.9±10.248.9 ± 10.2 DM-WE DM-WE 51.6±10.451.6 ± 10.4 DM-AE DM-AE 55.5±9.655.5 ± 9.6 DM-CM DM-CM 56.1±8.956.1 ± 8.9

1)NC: 정상 대조군, DM: 당뇨 대조군, DM-WE: 당뇨유발후 소나무잔나비버섯 자실체 열수추출물 1% 첨가식이군, DM-AE: 당뇨유발후 소나무잔나비버섯 자실체 알칼리추출물 1% 첨가식이군, DM-CM: 당뇨유발후 소나무잔나비버섯 배양균사체 추출물 1% 첨가식이군 1) NC: Normal control group, DM: Diabetic control group, DM-WE: Dietary supplementation of pine needle butterfly fruit fruit hot water extract after diabetes induction, DM-AE: Dietary addition of pine needle butterfly fruit fruit alkali extract after diabetes induction, DM-CM: Addition of 1% of pine myrtle mushroom culture mycelium extract after diabetes induction

상기 결과를 종합해 볼 때, 소나무잔나비버섯 추출물을 당뇨유발된 흰쥐에 4주간 식이투여하면, 당뇨에 의해 유도된 중성지질, 총 콜레스테롤 및 LDL 콜레스테롤 함량을 감소시킬 수 있음을 확인하였으며, 효과는 소나무잔나비버섯 자실체 알칼리추출물이 가장 우수함을 알 수 있었다. Taken together, the results of four weeks of dietary administration of pine beetle mushroom extract to the diabetic rats, it was confirmed that can reduce the content of triglycerides, total cholesterol and LDL cholesterol induced by diabetes, the effect is pine It was found that the fruit extract of the fruit of Janavier mushroom was the most excellent.

실시예 4: 본 발명 소나무잔나비버섯 추출물의 성분분석 Example 4 Component Analysis of the Pine Pine Butterfly Extract of the Present Invention

상기 실시예 2 내지 3에서 살펴본 바와 같이, 본 발명 소나무잔나비버섯 추출물은 당뇨유발된 흰쥐에서 당뇨합병증 예방효과 또는 당뇨 유도성 고콜레스테롤혈증 개선효과를 갖고 있다. 따라서, 상기 소나무잔나비버섯 추출물의 활성원을 알아보기 위해 분자량을 포함하여 그것의 성분을 분석하여 보았다. As described in Examples 2 to 3, the pine needles mushroom extract of the present invention has an effect of preventing diabetic complications or improving diabetes-induced hypercholesterolemia in diabetic rats. Therefore, in order to find out the active source of the pine berry butterfly extract was analyzed its components including the molecular weight.

상기 수득한 소나무잔나비버섯 자실체 열수추출물, 소나무잔나비버섯 자실체 알칼리추출물 및 소나무잔나비버섯 배양균사체 추출물을 공지의 방법(참조: 이신영, 강태수, 영지균사체의 액체배양에 의한 세포외 항암성 다당류의 구조분석, The Korean J. Mycology, 27: 76-81, (1999))에 준하여 DEAE-셀룰로즈(Cl-) 이온교환수지와 세파로즈 CL-4B 겔을 이용하여 순차적으로 분획, 정제한 후 GC를 이용하여 메틸화 분석을 수행하였다. 또한, 분자량 측정을 위하여는 분자량 200만, 50만, 30만의 덱스트란을 표품(Sigma사 제품)으로 사용하였다. 분획물의 단백질 구성을 알 기 위하여 280nm에서의 흡광도를 측정하였으며, 구성당을 알아보기 위하여 6탄당은 anthrone법(참조: Spiro RG, Analysis of sugars found in glycoprotein in Method in Enzymology, Academic Press, New York 8: 4-10, (1966))으로 분석하였다. The obtained pine leaf butterfly fruit fruit hot water extract, pine leaf butterfly fruit fruit alkali extract and pine leaf butterfly mushroom culture mycelium extract is a known method (see: Structure analysis of extracellular anticancer polysaccharides by liquid culture of Lee Shin-young, Kang Tae-soo, Ganoderma lucidum mycelium, According to The Korean J. Mycology, 27: 76-81, (1999)), fractionated and purified sequentially using DEAE-cellulose (Cl-) ion exchange resin and Sepharose CL-4B gel, and then methylated using GC. The analysis was performed. In addition, the molecular weight of 2 million, 500,000, and 300,000 dextran was used as a standard (product made by Sigma) for molecular weight measurement. The absorbance at 280 nm was measured to know the protein composition of the fraction, and hexasaccharide was analyzed by anthrone method (Spiro RG, Analysis of sugars found in glycoprotein in Method in Enzymology, Academic Press, New York 8). : 4-10, (1966)).

소나무잔나비버섯 자실체 열수추출물, 알칼리추출물 및 배양균사체 추출물로부터 추출한 다당류의 입체배위를 알아보기 위하여 친화크로마토그래피를 수행한 결과, 흡착부에서 당이 검출되지 않은 것으로 보아 상기 추출한 다당류가 β구조를 하고 있음을 알 수 있었다. 이를 구체적으로 알아보기 위하여 메틸화분석을 수행한 결과, 하기 표 8에서 보듯이, 2,3,4,6-tetramethyl glucose와 2,4,6-trimethyl glucose가 검출되어 β-글루코스가 1,3 결합한 β-1,3-glucan이 포함되어 있었으며, 그 외 현재까지 밝혀지지 않은 β-1,6-헤테로갈락토만난도 함유되어 소나무잔나비버섯 추출물의 주성분은 β-1,3-glucan과 β-1,6-헤테로갈락토만난이 결합되어 있는 β-1,3-글루카노-β-1,6-헤테로갈락토만난임이 확인되었으며, 이 복합다당체는 겔여과 결과 분자량이 30 내지 50만에 이르고 단백질과 결합하여 존재하는 단백다당체로 확인되었다. As a result of affinity chromatography to determine the steric coordination of the polysaccharides extracted from the fruit water extract, the alkaline extract and the culture mycelium extract of pine needles, the polysaccharides were β-structured because no sugar was detected in the adsorption part. And it was found. As a result of performing methylation analysis to specifically identify this, as shown in Table 8, 2,3,4,6-tetramethyl glucose and 2,4,6-trimethyl glucose were detected and β-glucose 1,3 bound. β-1,3-glucan was contained, and β-1,6-heterogalactomannan, which has not been identified until now, was mainly composed of β-1,3-glucan and β-1. It was confirmed that β-1,3-glucano-β-1,6-heterogalactomannan to which 6-heterogalactomannan is bound, and the complex polysaccharide had a molecular weight of 30 to 500,000 as a result of gel filtration. It was identified as a protein polysaccharide present in combination with.

표 8: 소나무잔나비버섯 자실체 추출물 및 배양균사체 추출물로부터 분리한 다당류의 구조분석결과 Table 8 : Structural Analysis of Polysaccharides Isolated from the Fruiting Body Extract of Pineapple Butterfly and Cultured Mycelia

메틸화 당 Methylated sugar 열수추출 다당류 (함량비)Hydrothermal Extract Polysaccharide (Content) 알칼리추출 다당류 (함량비)Alkali Extract Polysaccharide (Content) 균사체 배양액 (함량비)Mycelium broth (content ratio) 결합방식 Coupling method 2,3,4,6-tetramethyl-glucose2,3,4,6-tetramethyl-glucose 1.0 1.0 1.0 1.0 1.0 1.0 [Glc]1→   [Glc] 1 → 2,4,6-trimethyl glucose2,4,6-trimethyl glucose 4.24.2 3.83.8 4.04.0 →3[Glc]1→→ 3 [Glc] 1 → 2,3,6-trimethyl glucose2,3,6-trimethyl glucose 0.80.8 0.50.5 0.50.5 →4[Glc]1→→ 4 [Glc] 1 → 2,4- dimethylglucose2,4-dimethylglucose 0.50.5 0.60.6 0.50.5 →3,→6[Glc]1→→ 3, → 6 [Glc] 1 → 2,3,4- trimethyl- mannose2,3,4-trimethyl-mannose 0.7 0.7 0.4 0.4 0.4 0.4 →6[Man]1→→ 6 [Man] 1 → 2,3,4-trimethyl- galactose2,3,4-trimethyl-galactose 1.2 1.2 0.9 0.9 0.8 0.8 →6[Gal]1→→ 6 [Gal] 1 →

본 발명의 소나무잔나비버섯 자실체 추출물 및 배양균사체 추출물은 수정체 및 신장의 알도스환원효소(aldose reductase)의 활성을 억제하고, 중성지질, 총 콜레스테롤 및 LDL 콜레스테롤의 농도를 감소시키므로, 당뇨합병증의 치료 또는 예방효과를 나타내는 기능성 식품의 개발에 널리 활용될 수 있을 것이다. The extract of the fruiting body extract and culture mycelia of pine needles of the present invention inhibits the activity of aldose reductase of the lens and kidney, and reduces the concentration of triglyceride, total cholesterol and LDL cholesterol, thereby treating diabetic complications or It can be widely used in the development of functional foods with a protective effect.

Claims (11)

소나무잔나비버섯(Fomitopsis pinicola) 자실체를 세절 및 파쇄하고, 1N KOH로 1시간 동안 팽윤시킨 후, 파쇄기를 사용해 균질화하여 100mesh체로 여과하고, 염산으로 중화 및 증류수로 세척하고, 60℃에서 건조하여 얻은 소나무잔나비버섯의 자실체 알칼리 추출물을 포함하고, Fomitopsis pinicola fruiting body ( Fomitopsis pinicola ) is cut and crushed, swelled with 1N KOH for 1 hour, homogenized using a crusher, filtered through a 100 mesh sieve, neutralized with hydrochloric acid and washed with distilled water, dried pine at 60 ℃ It contains the fruiting body alkali extract of Xavier mushroom, 상기 소나무잔나비버섯의 자실체 알칼리 추출물은, 겔 여과 결과 분자량이 30 내지 50만이고, 2,3,4,6-테트라메틸 글루코오스, 2,4,6-트리메틸 글루코오스, 2,3,6-트리메틸 글루코오스, 2,4-디메틸 글루코오스, 2,3,4-트리메틸 만노오스 및 2,3,4-트리메틸 갈락토오스가 1.0 : 3.8 : 0.5 : 0.6 : 0.4 : 0.9의 중량비로 결합된 β-1,3-글루카노-β-1,6-헤테로갈락토만난-단백질복합체를 활성 성분으로 포함하는, The fruiting body alkali extract of the pine needles butterfly has a molecular weight of 30 to 500,000 as a result of gel filtration, 2,3,4,6-tetramethyl glucose, 2,4,6-trimethyl glucose, 2,3,6-trimethyl glucose , Β-1,3-glucano, 2,4-dimethyl glucose, 2,3,4-trimethyl mannose and 2,3,4-trimethyl galactose bound in a weight ratio of 1.0: 3.8: 0.5: 0.6: 0.4: 0.9 a -β-1,6-heterogalactomannan-protein complex as an active ingredient, 알도스환원효소의 활성증가에 기인하는 백내장 또는 신장병의 당뇨 합병증의 치료 또는 예방을 위한 조성물.A composition for the treatment or prevention of diabetic complications of cataracts or kidney disease caused by an increase in the activity of aldose reductase. 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete
KR1020070026809A 2007-03-19 2007-03-19 Fomitopsis pinicola Extract Having Diabetes Complication Preventive Effect and The Use Thereof KR100859986B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020070026809A KR100859986B1 (en) 2007-03-19 2007-03-19 Fomitopsis pinicola Extract Having Diabetes Complication Preventive Effect and The Use Thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070026809A KR100859986B1 (en) 2007-03-19 2007-03-19 Fomitopsis pinicola Extract Having Diabetes Complication Preventive Effect and The Use Thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020060001430 Division 2006-01-05 2006-01-05

Publications (2)

Publication Number Publication Date
KR20070073656A KR20070073656A (en) 2007-07-10
KR100859986B1 true KR100859986B1 (en) 2008-09-25

Family

ID=38508176

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070026809A KR100859986B1 (en) 2007-03-19 2007-03-19 Fomitopsis pinicola Extract Having Diabetes Complication Preventive Effect and The Use Thereof

Country Status (1)

Country Link
KR (1) KR100859986B1 (en)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
동아시아식생활학회지, 2005, 15(1), pp.100-105
한국식품저장유통학회지, 2005, 12(6), pp.583-590

Also Published As

Publication number Publication date
KR20070073656A (en) 2007-07-10

Similar Documents

Publication Publication Date Title
Reshetnikov et al. Medicinal value of the genus Tremella Pers.(Heterobasidiomycetes)
CN109825533B (en) Fermentation medium for preparing high-activity phellinus igniarius fermentation product and fermentation culture method thereof
Zhuang et al. Medicinal Value of Culinary-Medicinal Maitake Mushroom Grifola frondosa (Dicks.: Fr.) SF Gray (Aphyllophoromycetideae). Review.
Wong et al. Sclerotia: emerging functional food derived from mushrooms
JP4602674B2 (en) Maltase inhibitor
JP3284097B2 (en) Biological antioxidant function enhancer
CN101711774A (en) Application of Phellinus pini polysaccharide extract in preparing medicament for preventing and treating tumor metastasis
Tao et al. Examining the cultivation, degradation characteristics and health effects of the golden oyster mushroom Pleurotus citrinopileatus (Agaricomycetes): a review
JP2012158536A (en) Antidepressant
KR100859986B1 (en) Fomitopsis pinicola Extract Having Diabetes Complication Preventive Effect and The Use Thereof
JP2002087981A (en) Improving agent for metabolic disorder against sugar and lipid
KR100844980B1 (en) Method of producing a Healthy Mulberry Leaf Food by culture of Mushroom Mycelia
CN113875989B (en) Functionalized water-soluble nano-selenium, preparation method and application
CN105535035A (en) Inonotus obliquus fermentation culture composition and preparation method thereof
KR102580526B1 (en) Method of Preparing Soybean Fermented Mycelium
KR100859983B1 (en) Fomitopsis pinicola Extract Having Inhibitory Effect of Reactive Oxygen Spices Generated by Diabetes Mellitus and The Use Thereof
KR100859984B1 (en) Submerged-Liquid Culture Extract of Fomitopsis pinicola Mycelium and Composition Comprising the Same for Lowering Blood Sugar
KR100859985B1 (en) Fomitopsis pinicola Extract Having Inhibitory Effect of Pancreatic Cell Damage and The Use Thereof
CN112869156A (en) A method for preparing concentrated solution from Inonotus obliquus and birch juice
KR20140024549A (en) Method for manufacturing functional mushroom rice
KR20080070417A (en) Mycelia and fruiting bodies of auricularia auricula-judae having hypolipidemic effect and method for preparing the same
KR100778940B1 (en) Extraction method of polysaccharides from fruit body of fomitopsis pinicola
WO2007078157A1 (en) Fomitopsis pinicola extract and a process for manufacturing the same
KR20120132646A (en) Liquid cultivating method of Phellinus linteus increasing antioxidant and immunostimulating activity
WO2007091827A1 (en) Extract from submerged culture of fomitopsis pinicola mycelia and hypoglycemic composition comprising the same

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120918

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20130916

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20140916

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20150916

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20170912

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20180917

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20190918

Year of fee payment: 12